FAQ

rolapitant hydrochloride

Known as: Rolapitant Monohydrochloride Monohydrate, 1,7-Diazaspiro(4.5)decan-2-one, 8-(((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-, Monohydrochloride, Monohydrate, (5S,8S)-, Rolapitant HCl 
The hydrochloride salt form of rolapitant, an orally bioavailable, centrally-acting, selective, neurokinin 1 receptor (NK1-receptor) antagonist with… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2016-2018
012320162018

Related topics

Related topics

3 relations

Narrower (2)

SCH 619734Varubi
rolapitant

Related mentions per year

Related mentions per year

2006-2018
20002005201020152020
rolapitant hydrochloride
rolapitant
Varubi
SCH 619734

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection.
Prophylaxis or therapy with a combination of a neurokinin 1 (NK-1) receptor antagonist (RA), a 5-hydroxytryptamine-3 (5-HT3) RA… (More)
Is this relevant?
2018
2018
Absorption, metabolism, and excretion of the antiemetic rolapitant, a selective neurokinin-1 receptor antagonist, in healthy male subjects.
Rolapitant is a neurokinin-1 receptor antagonist that is approved in combination with other antiemetic agents in adults for the… (More)
Is this relevant?
2018
2018
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride.
Prophylaxis or therapy with a combination of a neurokinin 1 (NK-1) receptor antagonist (RA), a 5-hydroxytryptamine- 3 (5-HT3) RA… (More)
Is this relevant?
Review
2017
Review
2017
Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations
Knowledge of the involvement of the neurokinin substance P in emesis has led to the development of the neurokinin-1 receptor… (More)
  • table 1
  • table 4
  • table 5
Is this relevant?
Review
2016
Review
2016
Rolapitant hydrochloride: prophylactic treatment for chemotherapy-induced nausea and vomiting.
Chemotherapy-induced nausea and vomiting (CINV) is a significant clinical issue which affects patients' quality of life as well… (More)
Is this relevant?